USFDA makes 'certain' observations for Torrent Pharma's Indrad plant

The audit at Indrad plant of the company was carried out by the United
States Food and Drug Administration (USFDA) in April.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-makes-certain-observations-for-torrent-pharmas-indrad-plant/articleshow/69053644.cms

Comments

Popular posts from this blog

The Scroll and the Revolution: The Dilemmas of Writing about the Jews of Cuba

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

The Right Tool for the Job: Foreign Policy Effectiveness and Nuclear Proliferation